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The syngeneic or autologous mixed  leukocyte reaction  (MLR)  is the proliferation 
that  occurs  when  T  lymphocytes  are  co-cuhured  with  Ia-positive  autologous  or 
syngeneic non-T cells.  An autologous MLR  was  first  described  in  mice  (1)  and  has 
since  been  studied  in  human  (2-4),  murine  (5,  6),  and  guinea  pig  (7)  systems. 
Although  the  characteristics  of both  the  responder  and  stimulator  cell  populations 
have  been  clarified,  some  of the  central  questions  regarding  the  syngeneic  MLR 
remain  unanswered.  Is anti-self reactivity the property of all  antigen-specific T  cells 
or  is  there  a  unique  T  cell  subpopulation  that  responds  to self-Ia  molecules  in  the 
absence of foreign antigen?  If the  latter  is correct,  what  is the physiologic role of a 
population  of T  cells  that  presumably  possesses  receptors  for self I  region-encoded 
antigens? 
In the present report, we describe the initial characterization of several autoreactive 
T  cell hybridomas derived from the fusion of (BALB/c X A/J)F1 [CAF1] lymphocytes 
with  the  BW 5147  tumor line.  These  lines secrete  interleukin  2  (IL-2)  in serum-free 
medium only when challenged with I-A d-positive stimulator cells. The availability of 
large numbers of cloned autoreactive T  cells should greatly facilitate further analysis 
of the role of this unique cell population  in the regulation of the immune response. 
Materials  and Methods 
Animals.  B 10.A and A/J strains were purchased from The Jackson Laboratory, Bar Harbor, 
ME.  The  B10.A(4R)  strain  was  purchased  from  Simonsen  Laboratories,  Gilroy,  CA,  and 
the  D2.GD strain  was the kind  gift  of Dr.  David  Sachs  (National  Cancer Institute,  NIH). 
BALB/c AnN, (BALB/c ×  A/J)F1 [CAF1], and B10.D2nSnN strains were obtained from the 
Division of Research Services,  NIH. 
Production of T Cell Hybridomas.  The procedure for the production of T cell hybridomas was 
similar to that described by Heber-Ka~z et al. (8) and Kappler et al.  (9). Antigen-specific T cell 
blasts were prepared by culturing 4 ×  106 nylon wool-passed lymph node (LN) cells from CAFI 
mice,  which had been immunized in the footpads 7 d  previously with  10/Lg of pork insulin 
(PINS) (Sigma Chemical Co., St.  Louis, MO) with  l0  s x-irradiated CAF1 spleen cells in 2 ml 
Eagle's Hank's amino acids (NIH media production) plus  10% fetal calf serum (FCS)  and  10 
/Lg/ml PINS. After 3 d of culture, cells were harvested, enriched for blasts on a Ficoll density 
gradient, and mixed with the hypoxanthine, aminopterine, thymidine (HAT)-sensitive T  cell 
line BW 5147,  an AKR thymoma obtained from the Salk Institute Cell Distribution  Center 
(La Jolla, CA), in a ratio of 1:2. Fusion was carried out using 50% (vol/vol) polyethylene glycol 
1,000 (Baker Chemical Co., Phillipsburg, N  J) for 8 min. 3 ×  105 cells were plated out into 96- 
well Costar plates (Costar, Data Packaging, Cambridge, MA) containing 7 ×  10  a x-irradiated 
(2,000 rad) peritoneal washout cells in 0.2 ml of fusion medium. The fusion medium was 1:1 
EHAA:RPMI  1640  (Biofluids,  Rockville,  MD)  containing  20%  FCS,  HAT,  L-glutamine, 
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penicillin-streptomycin, 2-mercaptoethanol, and  Hepes buffer. After  7 d,  hybridomas were 
picked and transferred to 24-well Costar plates, expanded, and tested for antigen-specific IL-2 
production. 
Assay of T Cell Hybridomas  for Activity.  1 ×  105 T  hybridoma cells were co-cultured with 2.5 
×  105 CAF1 spleen  cells in the presence or absence of antigen in 0.2  ml of fusion  medium 
without HAT. In some experiments, Iscove's medium (10) was substituted for fusion medium. 
After 2 d of culture, supernatants were collected  and assayed for IL-2 content in a secondary 
culture by using HT-2 cells, an IL-2-dependent T  cell line developed by Dr. James Watson, 
University of Auckland,  Auckland,  New  Zealand,  and  provided by Dr.  Phillipa  Marrack, 
National Jewish Hospital, Denver, CO.  2-4 X  103 HT-2 cells were cultured  for 24 h  in the 
presence of 35% primary culture supernatant, and the degree of stimulation was measured by 
the incorporation of [3H]thymidine (6.8 Ci/ml; New England Nuclear, Boston, MA) into DNA. 
B Cell-B Lymphoma Antigen-presenting Hybridomas.  TA3 is an LAd/a/LEa/k-bearing B cell-B 
lymphoma hybridoma with potent I region-restricted stimulatory capability, prepared by Dr. 
T. Hamano (Laboratory of Microbial Immunity, NIH) by fusing  lipopolysaccharide (LPS)- 
activated CAF1 B cells with a drug-marked variant ofa BALB/c B 1ymphoma (see ref.  I 1). 
Menodonal Antibodies.  The  monoclonal  antibodies  34-5-4  (oJ-A~),  14-4-4 (a/-Ed~),  and 
17-3-3  (directed  against the combinatorial Ia molecule, fl~motE) were the kind gift of Dr. David 
Sachs, NCI, NIH. The 10-2-16 monoclonal antibody (od-A  k) was the gift of Dr. Richard Hodes, 
NCI, NIH. The 34-5-4, 14-4-4, and 10-2-16 antibodies were in ascites form and were used at a 
dilution of 1:1,000 (vol/vol) in culture. The 17-3-3 antibody was a culture supernatant and was 
used at a dilution of 1:20 (vol/vol). 
Results and Discussion 
Our initial attempts at the production of autoreactive T  cell hybridomas involved 
the fusion of blasts obtained from primary or secondary syngeneic MLR cultures with 
the BW 5147 line, using the methods described by Kappler et al. (9) and Heber-Katz 
et al. (8). No hybridomas specific for syngeneic stimulator cells could be isolated from 
such  fusions.  However,  in  the  course  of the  production  of antigen-specific  T  cell 
hybridomas from CAF1 mice specific for PINS, we noticed that a large percentage of 
these hybridomas responded to H-2-matched spleen cells in the absence of the priming 
antigen. 44 positive wells were randomly picked, expanded for testing, and of these 26 
had activity. The specificity of a number of these T  cell hybridomas is shown in Table 
I. None of these hybridomas produced IL-2 in the absence of stimulator cells or in the 
presence  of  insulin  alone.  8  hybridomas  (group  III)  responded  to  H-2-matched 
stimulator cells only in the presence of the priming antigen (PINS),  14 demonstrated 
an  antigen-independent  response  (group  I),  and  4  (group  II)  exhibited  a  mixed 
response, i.e., they had some response to CAF1 spleen cells alone but gave a superior 
response to CAF1 spleen cells in the presence of PINS. Two hybridomas (B3 and B4), 
whose proliferative response was restricted to the BALB/c parental strain  (Table I), 
were selected for further study and cloned by limiting dilution. 
Studies (12) with heterogenous T cell populations have shown that antigens encoded 
in  the I  subregion of the MHC  are the  target antigens  in  the syngeneic MLR.  We 
therefore used stimulators from parental  H-2-recombinant strains to map the genes 
that encode the antigen required  for stimulation of the B3 autoreactive hybridoma 
(Table  II).  Spleen  cells  from  the  CAF1,  BI0.D2,  and  D2.GD,  all  of which  bear 
Kd/I-A  d, elicited  a  good response, whereas cells from B10.A and B10.A(4R),  which 
bear Kk/I-A  k, were nonstimulatory. These results indicate that antigens encoded  in 
the  K  region  and/or  the  I-A  subregion  of the  H-2  d  haplotype  are  involved  in 
stimulating the autoreactive hybridoma B3. 
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TABLE  I 
Characteristics of T Cell Hybridomas Derived  from the Fusion of PINS-primed 
T  Cell Blasts  with BW 5147 
Hydridoma 
number 
[SH]TdR Incorporation* 
CAF1 spleen  CAF~  spleen  +  A/J spleen  BALB 
PINS  spleen 
Group I 
Group II 
A2  17,170  19,218 
AI3  17,070  16,966 
AI7  9,090  10,024 
B3  39,419  27,945 
B4  18,742  18,613 
BI7  34,720  28,444 
A5  4,070  16,496 
A12  12,597  27,415 
A23  8,270  18,539 
BI8  14,852  30,800 
Group III  AI6  690  15,653 
BI4  809  23,913 
844  19,612 
382  10,641 
*  1 ×  l0  s T  hybridoma cells were co-cultured  with 2.5 ×  l0  b spleen cells in the presence 
or absence of antigen in 0.2 ml of fusion  medium without HAT. After 2 d  of culture, 
supernatants were collected and assayed for IL-2 content  in a  secondary culture on 
HT-2 cells. 2-4 ×  108 HT-2 cells were cultured for 24 h in the presence of 35% primary 
culture super'natant, and the degree of stimulation was measured by the incorporation 
of [aH]thymidine  into DNA. 
TABLE II 
Spleen Cells from I Region Recombinant Strains Map the Target Antigen of 
the Autoreactive T Cell Hybn'doma B3 to I~/I-A a 
Source of stimulator cells  MHC  alleles  Proliferative  response 
cpm 
(BALB/c ×  A/J)F~  dddddddd  34,187 
kkkkkddd 
BI0.D2  dddddddd  35,527 
BI0.A  kkkkkddd  1,820 
D2.GD  ddbbbbbb  47,414 
BI0.A(4R)  kkbbbbbb  1,001 
l0  b T  hybridoma cells were co-cultured with 2.5 ×  10  s of the designated spleen cells, and 
the assay was performed as detailed  in  the legend to Table I. 
reagents in the cultures (Table III).  As a  source of homogeneous stimulator cells  in 
the  blocking  experiments,  we  used  an  l-Aa/"/I-Ea/k-bearing  B  cell-B  lymphoma 
hybridoma, TA3 (identical results were obtained using CAF1 or BALB/c spleen cells 
as stimulator cells). Addition of a  monoclonal anti-l-A s  antibody (34-5-4)  decreased 
the production of IL-2 by two B3 reclones, B3/C4 and B3/C5, by >99%. Three other 
monodonal  reagents  (10-2-16,  14-4-4  and  17-3-3)  reactive  with  other  specificities 
present on the TA3 cells did not inhibit the production of IL-2 by the autoreactive 
hybridomas. These three reagents did, however, appropriately inhibit the production 
of IL-2 by two other antigen-specific hybridomas, one specific for hen egg lysozme in 
the context of I-A ~ (10-2-16) and the other specific for cytochrome c in the context of 
the combinatorial Ia molecule (14-4-4 and 17-3-3)  (data not shown). 
To  rule out  the possibility  that  the "autoreactive"  hybridomas were  recognizing 
FCS components, such as albumin or bovine insulin in association with syngeneic Ia 
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TABLE III 
Blocking Studies with Monoclonal Anti-la Antibodies Confirm That the 
Autoreactive Hybridomas Recognize Determinants in the I-A d Subregion 
[aH]TdR incorporation in the presence of TA3 stimulator cells* 
Monoclonal 
antibody 
Experiment 1  Experiment 2  Experiment 3 
B3/C5  B3/C4  B3/C5  B3/C4  B3/C5 
None  36,084  31,906  32,449  31,985  17,375 
34-5-4(al-A  ~t)  767  2,340  307  682  441 
10-2-16(al-A  k  )  23,797  34,041  --  --  -- 
14-4-4(aI-E  aJ'  )  37,978  38,569  36,979  33,178  18,074 
17-3-3(aflAt~E)  35,142  34,273  34,986  38,521  19,215 
* B3/C5 and B3/C4 are reclones of the original autoreactive hybridoma B3. These hybrids 
are Ia negative, as determined by cytotoxicity with the above reagents. 105 T hybridoma 
cells were co-cultured with 104 irradiated (10,000 rad from a 137cesium source) TA3 cells 
(see ref.  11) in the presence of the designated antibodies in Iscove's medium prepared 
without exogenous bovine serum albumin or insulin. The remainder of the assay was 
performed as described in Table I. 
TABLE  IV 
Two Autoreactive Hybridomas  Respond to Self H-2 a Determinants  in 
Serum-free, Insulin-free  Medium 
Stimulator cell 
['~H]-TdR incorporation 
B3  B4 
Experiment I  A/J  422  761 
(2AFt  61,407  31,425 
TA3  70,173  30,858 
Experiment II  CAFl  19,493  31,149 
TA3  27,835  17,375 
Experiment III  TA3 (grown in  26,017 
Iseove's me-  (grown in Iscove's medium) 
dium) 
105 hybridoma cells were co-cultured with the designated stimulator cells in  modified 
Iscove's medium  (10)  prepared without  exogenous bovine serum  albumin,  insulin, or 
transferrin, and the supernatants were assayed for IL-2 activity as detailed in the legend 
to Table I. 
medium  (10)  prepared without  bovine serum  albumin,  insulin,  or transferrin.  The 
results of two such experiments (Table IV) demonstrated that the induction  of IL-2 
production by the appropriate parental strain stimulator cells in two of the autoreac- 
tive hybridomas  (B3  and  B4)  was unimpaired  in  the  presence of such  serum-free, 
transferrin-free, and insulin-free medium. To definitively rule out the possibility that 
foreign serum components that adsorbed to either the hybridoma or stimulator cell 
surface were responsible  for activation of the  hybridomas, both  B3  and  TA3 were 
grown in Iscove's media for 48 h before use in the experiments, with no difference in 
the results obtained (Table IV, experiment 3). The addition of PINS or FCS to these 
cultures had no effect on the response obtained  (not shown). Although  it is possible 
that  significant  amounts of serum components remain cell associated after 48  h  of 
culture in serum-free medium, we believe this is unlikely because a T  cell hybridoma 
specific for FCS components cultured under these same conditions was inactive in the 
absence of added FCS. 
In spite of the fact that  the addition  of PINS had  no augmenting effect on  IL-2 
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could  only be  identified  during  the  course of studies  designed  to  produce  PINS- 
specific,  I  region-restricted  hybridomas.  The  possibility  must,  therefore,  still  be 
considered that some relationship exists between the autoreactive and antigen-specific 
T  cell populations.  First,  it  is intriguing to speculate that  these cells bear antigen- 
specific receptors as well as high-affinity anti-self receptors. Indeed, recent work by 
Dos Reis and Shevach (13), which demonstrated direct activation of antigen-specific 
T  cell clones by unmodified self-Ia antigens,  suggests that  some antigen-specific T 
cells can be directly activated in an antigen-independent manner by Ia-positive cells 
through their receptors for self-Ia molecules. 
Alternatively, it is possible that the autoreactive T  cell is directly activated by the 
antigen-specific T  cell via an idiotypic-anti-idiotypic receptor network, although this 
possibility seems unlikely because the autoreactive cells can be activated by unmodi- 
fied Ia antigens.  Further studies  to evaluate  the  relationship  between autoreactive 
and  antigen-specific T  cells  by  using  assays  of T  cell  specificity, such  as  help  or 
suppression  of insulin-specific antibody production by B  lymphocytes, are  now  in 
progress. 
Summary 
We  produced  autoreactive  T  cell  hybridomas  that  can  be  induced  to  secrete 
interleukin 2 by co-culture with either syngeneic splenic stimulator cells or syngeneic 
Ia-positive  B  cell-B  lymphoma  hybridomas.  These  autoreactive  hybridomas  arose 
from the fusion of pork insulin-primed lymph node T  cells with the AKR thymoma 
BW  5147  and  occurred  at  a  higher  frequency  than  the  expected  insulin-specific 
hybridomas. Mapping studies using recombinant strains and blocking studies using 
monoclonal  anti-Ia  antibodies  localized  the  stimulatory  determinant  to  the  I-A a 
subregion of the major histocompatibility complex. These T  cell hybridomas did not 
appear to be directed at  any foreign antigen present in the culture system because 
activation  occurred  in  serum-free,  insulin-free  medium  (Iscove's  medium).  Such 
hybridomas should prove to be a potent tool in studying the biologic significance and 
function of the autoreactive response. 
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